@tompowles1 @MichvdHeijden Love those - putting data in context - what a delight to meet you in person - till we meet again soon - stay human & awesome - thank you ,@tompowles1
English
Baz Akladios
64 posts
Baz Akladios
@BassemAkladios
Human being - Pharmacist - Medical Affairs - PhD in Molecular Genetics & Oncology - Love Science - Passionate about Serving Patients - Opinions my own
Sydney, New South Wales Katılım Kasım 2015
1.1K Takip Edilen218 Takipçiler
The INDIBLADE Trial (n=50): Neoadjuvant Ipi/nivo then Chemoradiotherapy in muscle invasive bladder cancer shows 2 yr Bladder-Intact EFS of 78% & 2 yr OS of 96%. #GU26 @MichvdHeijden . ⬆️⬆️ than previous chemo/rad trials. Only 39% ctDNA+ve at baseline suggests a lower risk population compared to NIAGARA (57%). CtDNA clearance with IPI/Nivo=76% is ⬆️ (gem/cis/durva=70%). IPI/nivo/TMT looks good. VOLGA is the last chance to answer the CTLA4 question. Outcome in MIBC is strongly influenced by the presence on MRD at baseline (2 yr DFS for IPI/nivo surgery was ~70%).
English
@PGrivasMDPhD @crisbergerot @ASCO @montypal @neerajaiims @apolo_andrea @AndreaNecchi @NazliDizman @OncoAlert @ASCOPres You are the best! Always spreading respect, love and inclusion. We are lucky to have a human & a clinician like you in our field. Was a delight to see you in SF :) till we meet again soon
English
Phenomenal #GU26 @ASCO meeting with impressive data, discussions & interactions with colleagues! Together we learn & serve patients! Research paves the way forward, implementation/access: keys!
@montypal @neerajaiims @apolo_andrea @AndreaNecchi @NazliDizman @OncoAlert @ASCOPres
English
QME
New 2025 data from @aihw - These stats confirm the critical need for continued research and optimal care. The work of groups like @ANZUP and @USANZ is essential for advancing treatments and tackling these epidemiological challenges. #Urology #CancerTrials
English
New 2025 data from @aihw Kidney Cancer (#7) & Bladder Cancer (#11) are now both classified as "common" cancers. Most alarming is the 69% surge in kidney cancer incidence among 40-49 year-olds since 2000. We need to understand the drivers behind this. @ANZUPtrials @USANZUrology
English
New 2025 data from @aihw reveals major shifts in GU cancers in Australia. 🔵 Prostate Cancer remains #1 diagnosed. Despite a 96% 5-yr survival rate, the absolute number of deaths is rising (~4,000 est.), a direct challenge from our ageing population. @USANZUrology @ANZUPtrials
English
English
Has been my honor & privilege to give back to @ASCO, our prof oncology group, to further mutual mission - conquering cancer thru research, education, & care. Together stronger for our patients & community.
Thank you @ASCO for this FASCO distinction! Adding to credentials w pride
ASCO@ASCO
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiVu
English
Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 bit.ly/4lXkLtB and bit.ly/4nNIyOh @PCFnews @urotoday @OncoAlert
Neeraj Agarwal, MD, FASCO@neerajaiims
Just in👉Two @TheLancetOncol papers on patient-reported QOL results in ph3 TALAPRO-2 trial👉in all-comer & HRR deficient mCRPC #ProstateCancer pts👉Improved OS without compromising QOL👇Links: bit.ly/3DWHlSR & bit.ly/3E3SSQi @urotoday @OncoAlert @PCFnews 👇
English
May is Bladder Cancer Awareness Month #BladderCancer
Bladder cancer is :
- the 11th most common cancer in Australia.
- Affects people of all ages.
- Over 3000 Australians are diagnosed each year.
- Is much more treatable if detected early.
English
English
MASSIVE congratulations to the entire ASPiRATION-2 Liquid team on their hard work to obtain $14.7m #MRFF Frontier Grant 🎉
NHMRC CTC@TrialsCentre
Congrats to the ASPiRATION-2 Liquid study team on their #MRFF Frontier Grant! #LungCancer is the top cancer killer and traditional treatments often fail. This study will evaluate the use of serial 'liquid biopsies'—simple blood tests—to tailor treatments without invasive procedures. Read more 🔗bit.ly/4lr8WfE @TOGAANZ @PeterMacCC @UniMelb @GenCancerCentre @syd_health
English
Baz Akladios retweetledi
April is #TesticularCancerAwarenessMonth – a time to recognise the prevalence of this Below the Belt cancer and the incredible people working to improve outcomes.
Their dedication is driving better treatments, improving patient care, and bringing hope to those affected.💙👏
English
@_ShankarSiva @RenuEapen @gu_onc @declangmurphy @DrDanielMoon @lawrentschuk @MaartenAlbersen @Silke_Gillessen @PeterMacCC @DrMHofman @VedangMurthy @drMPerera Awesome work @RenuEapen & all LuTectomy Team
English
Awesome to see @RenuEapen (well partially, notwithstanding an annoyingly large lecturn) giving a tour de force of ‘what’s hot’ in theranostics + surgery in #prostatecancer at #EAU25 👏🏽👏🏽👏🏽
English
English
@RenuEapen Final PhD Confirmation was highlight of the month! Massive achievement combining so many skills #LuTectomy, clinical trial, translational research, surgery and nuclear medicine.
Huge congratulations. Co supervising with @declangmurphy and Prof Paul Neeson and mentor Prof Henderson has been such a pleasure.
@UniMelb @PeterMacCC @pros_tic @PCF_Science
Melbourne, Victoria 🇦🇺 English
@RenuEapen @pros_tic @Neeson_Lab @DrMHofman @declangmurphy @PCF_Science @RenuEapen million congratulations / Kudos to your commitment and hard work and the support of all the awesome people around you @pros_tic @declangmurphy @DrMHofman
English
Such a relief to get here! Only possible with the amazing team @pros_tic and @Neeson_Lab, wonderful supervisors @DrMHofman @declangmurphy and invaluable support and friendship from @PCF_Science!
Michael Hofman@DrMHofman
@RenuEapen Final PhD Confirmation was highlight of the month! Massive achievement combining so many skills #LuTectomy, clinical trial, translational research, surgery and nuclear medicine. Huge congratulations. Co supervising with @declangmurphy and Prof Paul Neeson and mentor Prof Henderson has been such a pleasure. @UniMelb @PeterMacCC @pros_tic @PCF_Science
English
Baz Akladios retweetledi
Great to see @PeterMacCC featuring our own @RenuEapen to celebrate #IWD2025 #ForAllWemenandGirls! Nice GU Cast mention Renu! petermac.org/about-us/news-…
English
@LauraBukavinaMD Was awesome having you in AUS - learnt heaps from you - make sure to come back!
English
Thank you for having me .. what a great conference full of clinically relevant discussions and plenaries #USANZ25 in a beautiful country 🇦🇺🐨🦘
USANZ@USANZUrology
@LauraBukavinaMD presents on circulating tumour DNA in #bladdercancer and offers considerations pre- and post-cystectomy. Dr Bukavina is Assistant Professor of Urology at @ClevelandClinic. #USANZ25 This presentation was part of Plenary 6, the @USANZUrology & @Uroweb session.
English
Thankyou to everyone for your kind thoughts and well wishes. I have undergone what is a complex surgery and am incredibly grateful to my medical team at Chris O’Brien Lifehouse for their exceptional care and support, particularly A/Prof Brindha Shivalingam. I would also like to express my heartfelt thanks to my family & friends for their unconditional love and unwavering support throughout this journey. Now I am focused on my recovery and will share more updates when I am able. Thankyou in advance for your patience and understanding.
@COBLH
@SydneyLHD
@Sydney_Uni
@Dr_Brindha
English
@AzadOncology @UniMelb @melkauf2018 @PeterMacCC @pros_tic @ANZUPtrials @COSAoncology @neerajaiims @EdmondMKwan @PCFnews @DrMHofman @gu_onc @_ShankarSiva Congratulations Prof @AzadOncology - so well deserved
English
Thanks to @UniMelb for the Xmas present: promotion to Full Professor. Too many people to thank - my parents & brother, my wife @melkauf2018, many wonderful colleagues & collaborators, industry partners, & all the patients who have selflessly supported #ProstateCancer research 🙏
English